Opus Genetics (IRD) Invested Capital (2010 - 2026)
Opus Genetics (IRD) reported Invested Capital of -$45.8 million for Q1 2026, down 357.68% year-over-year from $17.8 million in Q1 2025, and down 398.64% on a QoQ basis from $15.3 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Invested Capital data on file, last reported at -$45.8 million in Q1 2026.
- Quarterly Invested Capital fell 357.68% year-over-year to -$45.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$45.8 million (down 357.68% YoY) and the FY2025 annual result came in at $15.3 million, up 128.26% from the prior year.
- Invested Capital declined to -$45.8 million in Q1 2026 per IRD's latest filing, from $15.3 million in the prior quarter.
- Across five years, Invested Capital topped out at $50.4 million in Q3 2023 and bottomed at -$45.8 million in Q1 2026.
- The 5-year median for Invested Capital is $29.3 million (2025), against an average of $25.9 million.
- The widest annual swing landed in 2023, when Invested Capital soared 324.14%; it then plunged 357.68% in 2026.
- Tracing IRD's Invested Capital over 5 years: stood at $46.2 million in 2022, then rose by 7.93% to $49.9 million in 2023, then slumped by 86.53% to $6.7 million in 2024, then jumped by 128.26% to $15.3 million in 2025, then plunged by 398.64% to -$45.8 million in 2026.
- Per Business Quant, the three latest IRD Invested Capital figures stand at -$45.8 million (Q1 2026), $15.3 million (Q4 2025), and $27.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 110.96 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -45.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -45.84 Mn |
| Dec 31, 2025 | 15.35 Mn |
| Sep 30, 2025 | 27.29 Mn |
| Jun 30, 2025 | 29.27 Mn |
| Mar 31, 2025 | 17.79 Mn |
| Dec 31, 2024 | 6.72 Mn |
| Sep 30, 2024 | 34.30 Mn |
| Jun 30, 2024 | 40.64 Mn |
| Mar 31, 2024 | 46.06 Mn |
| Dec 31, 2023 | 49.91 Mn |
| Sep 30, 2023 | 50.38 Mn |
| Jun 30, 2023 | 37.70 Mn |
| Mar 31, 2023 | 41.25 Mn |
| Dec 31, 2022 | 46.24 Mn |
| Sep 30, 2022 | 11.88 Mn |
| Jun 30, 2022 | 14.60 Mn |
| Mar 31, 2022 | 17.49 Mn |
| Dec 31, 2021 | 22.22 Mn |
| Sep 30, 2021 | 20.57 Mn |
| Jun 30, 2021 | 22.55 Mn |
| Mar 31, 2021 | 9.82 Mn |
| Dec 31, 2020 | -13.47 Mn |
| Sep 30, 2020 | -9.41 Mn |
| Jun 30, 2020 | -8.78 Mn |
| Mar 31, 2020 | -8.46 Mn |
| Dec 31, 2019 | -4.85 Mn |
| Sep 30, 2019 | 11.76 Mn |
| Jun 30, 2019 | 13.62 Mn |
| Mar 31, 2019 | 15.94 Mn |
| Dec 31, 2018 | -1.70 Mn |
| Sep 30, 2018 | 6.41 Mn |
| Jun 30, 2018 | 11.42 Mn |
| Mar 31, 2018 | 14.97 Mn |
| Dec 31, 2017 | 16.77 Mn |
| Sep 30, 2017 | 15.12 Mn |
| Jun 30, 2017 | 15.90 Mn |
| Mar 31, 2017 | 1.13 Mn |
| Dec 31, 2016 | 17.06 Mn |
| Sep 30, 2016 | 17.24 Mn |
| Jun 30, 2016 | 15.81 Mn |
| Mar 31, 2016 | 17.21 Mn |
| Dec 31, 2015 | 18.78 Mn |
| Sep 30, 2015 | 17.71 Mn |
| Jun 30, 2015 | 21.43 Mn |
| Mar 31, 2015 | 23.38 Mn |
| Dec 31, 2014 | 26.58 Mn |
| Sep 30, 2014 | 28.60 Mn |
| Jun 30, 2014 | 30.31 Mn |
| Mar 31, 2014 | 28.03 Mn |
| Dec 31, 2013 | 12.63 Mn |
| Sep 30, 2013 | 9.85 Mn |
| Jun 30, 2013 | 5.50 Mn |
| Mar 31, 2013 | 8.38 Mn |
| Dec 31, 2012 | 9.53 Mn |
| Sep 30, 2012 | 4.74 Mn |
| Jun 30, 2012 | 7.67 Mn |
| Mar 31, 2012 | 8.66 Mn |
| Dec 31, 2011 | 10.71 Mn |
| Sep 30, 2011 | 10.17 Mn |
| Jun 30, 2011 | 11.48 Mn |
| Dec 31, 2010 | 10.40 Mn |